Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable…
Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity…
BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042…
Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour …
CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug…
In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company specializing in non-small…
ROSEBURG, Ore., April 24, 2025 /PRNewswire/ -- Marco Pharma International, a leading provider of German homeopathic and herbal remedies, will participate…
Leading managed service provider deepens capabilities to advance R&D, improve time-to-market, and ensure regulatory compliance DENVER, April 24, 2025 /PRNewswire/…
Held during Abu Dhabi Global Health Week, the roundtable united global health leaders to shape a Declaration on AI governance…
Additional space underscores commitment to innovative patient support service offerings, powered by Cloud Script™ technology platform STERLING, Va., April 24,…